Status: current, Defined. Date: 31-Jan 2015. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1371261000168119 | Qlaira (2 x 3 mg tablets, 5 x 2 mg/2 mg tablets, 17 x 2 mg/3 mg tablets, 2 x 1 mg tablets, 2 x inert tablets), 3 x 28, blister packs | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 4140321000168110 | Qlaira (dienogest 3 mg + estradiol valerate 2 mg) tablet [17 tablets] (&) (dienogest 2 mg + estradiol valerate 2 mg) tablet [5 tablets] (&) (estradiol valerate 3 mg) tablet [2 tablets] (&) (estradiol valerate 1 mg) tablet [2 tablets] (&) (inert substance) tablet [2 tablets], 3 x 28 tablets, blister packs (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4145111000168114 | Qlaira (dienogest 3 mg + oestradiol valerate 2 mg) tablet [17 tablets] (&) (dienogest 2 mg + oestradiol valerate 2 mg) tablet [5 tablets] (&) (oestradiol valerate 3 mg) tablet [2 tablets] (&) (oestradiol valerate 1 mg) tablet [2 tablets] (&) (inert substance) tablet [2 tablets], 3 x 28 tablets, blister packs | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Qlaira (2 x 3 mg tablets, 5 x 2 mg/2 mg tablets, 17 x 2 mg/3 mg tablets, 2 x 1 mg tablets, 2 x inert tablets), 3 x 28, blister packs | has TPUU | Qlaira (estradiol valerate 2 mg + dienogest 2 mg) tablet | true | Inferred relationship | Some | 2 | |
| Qlaira (2 x 3 mg tablets, 5 x 2 mg/2 mg tablets, 17 x 2 mg/3 mg tablets, 2 x 1 mg tablets, 2 x inert tablets), 3 x 28, blister packs | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Qlaira (2 x 3 mg tablets, 5 x 2 mg/2 mg tablets, 17 x 2 mg/3 mg tablets, 2 x 1 mg tablets, 2 x inert tablets), 3 x 28, blister packs | Is a | Qlaira (2 x 3 mg tablets, 5 x 2 mg/2 mg tablets, 17 x 2 mg/3 mg tablets, 2 x 1 mg tablets, 2 x inert tablets), 3 x 28 | true | Inferred relationship | Some | ||
| Qlaira (2 x 3 mg tablets, 5 x 2 mg/2 mg tablets, 17 x 2 mg/3 mg tablets, 2 x 1 mg tablets, 2 x inert tablets), 3 x 28, blister packs | has container type | blister pack | true | Inferred relationship | Some | ||
| Qlaira (2 x 3 mg tablets, 5 x 2 mg/2 mg tablets, 17 x 2 mg/3 mg tablets, 2 x 1 mg tablets, 2 x inert tablets), 3 x 28, blister packs | has subpack | Qlaira (2 x 3 mg tablets, 5 x 2 mg/2 mg tablets, 17 x 2 mg/3 mg tablets, 2 x 1 mg tablets, 2 x inert tablets), 28, blister pack | true | Inferred relationship | Some | 1 | |
| Qlaira (2 x 3 mg tablets, 5 x 2 mg/2 mg tablets, 17 x 2 mg/3 mg tablets, 2 x 1 mg tablets, 2 x inert tablets), 3 x 28, blister packs | has TP | Qlaira | true | Inferred relationship | Some | ||
| Qlaira (2 x 3 mg tablets, 5 x 2 mg/2 mg tablets, 17 x 2 mg/3 mg tablets, 2 x 1 mg tablets, 2 x inert tablets), 3 x 28, blister packs | has TPUU | Qlaira (estradiol valerate 2 mg + dienogest 3 mg) tablet | true | Inferred relationship | Some | 3 | |
| Qlaira (2 x 3 mg tablets, 5 x 2 mg/2 mg tablets, 17 x 2 mg/3 mg tablets, 2 x 1 mg tablets, 2 x inert tablets), 3 x 28, blister packs | has TPUU | Qlaira (estradiol valerate 1 mg) tablet | true | Inferred relationship | Some | 4 | |
| Qlaira (2 x 3 mg tablets, 5 x 2 mg/2 mg tablets, 17 x 2 mg/3 mg tablets, 2 x 1 mg tablets, 2 x inert tablets), 3 x 28, blister packs | has TPUU | Qlaira (inert substance) tablet | true | Inferred relationship | Some | 5 | |
| Qlaira (2 x 3 mg tablets, 5 x 2 mg/2 mg tablets, 17 x 2 mg/3 mg tablets, 2 x 1 mg tablets, 2 x inert tablets), 3 x 28, blister packs | has TPUU | Qlaira (estradiol valerate 3 mg) tablet | true | Inferred relationship | Some | 6 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR